Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD0328 in patients with schizophrenia
NCT00669903Phase 2Terminated
- Sponsor
- AstraZeneca
- Start
- Apr 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AZD0328 in schizophrenia, sponsored by AstraZeneca. Started Apr 2008; status: terminated.
02
Drugs
AZD0328
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00669903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00669903.